- Home
- TALO vs ARDX Comparison
TALO vs ARDX Comparison
Compare TALO & ARDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TALO
- ARDX
- Stock Information
- Founded
- TALO 2011
- ARDX 2007
- Country
- TALO United States
- ARDX United States
- Employees
- TALO N/A
- ARDX N/A
- Industry
- TALO Oil & Gas Production
- ARDX Biotechnology: Pharmaceutical Preparations
- Sector
- TALO Energy
- ARDX Health Care
- Exchange
- TALO Nasdaq
- ARDX Nasdaq
- Market Cap
- TALO N/A
- ARDX 1.3B
- IPO Year
- TALO N/A
- ARDX 2014
- Fundamental
- Price
- TALO $9.72
- ARDX $4.91
- Analyst Decision
- TALO Strong Buy
- ARDX Strong Buy
- Analyst Count
- TALO 9
- ARDX 9
- Target Price
- TALO $15.56
- ARDX $10.61
- AVG Volume (30 Days)
- TALO 1.9M
- ARDX 3.8M
- Earning Date
- TALO 05-05-2025
- ARDX 05-01-2025
- Dividend Yield
- TALO N/A
- ARDX N/A
- EPS Growth
- TALO N/A
- ARDX N/A
- EPS
- TALO N/A
- ARDX N/A
- Revenue
- TALO $1,972,191,000.00
- ARDX $333,615,000.00
- Revenue This Year
- TALO N/A
- ARDX $14.26
- Revenue Next Year
- TALO N/A
- ARDX $32.49
- P/E Ratio
- TALO N/A
- ARDX N/A
- Revenue Growth
- TALO 35.51
- ARDX 168.06
- 52 Week Low
- TALO $8.05
- ARDX $4.32
- 52 Week High
- TALO $14.67
- ARDX $9.33
- Technical
- Relative Strength Index (RSI)
- TALO 63.14
- ARDX 39.95
- Support Level
- TALO $9.01
- ARDX $5.00
- Resistance Level
- TALO $9.74
- ARDX $5.56
- Average True Range (ATR)
- TALO 0.32
- ARDX 0.26
- MACD
- TALO 0.14
- ARDX -0.05
- Stochastic Oscillator
- TALO 89.76
- ARDX 22.27
Stock Price Comparison Chart: TALO vs ARDX
■ TALO
■ ARDX
About ARDX Ardelyx Inc.
Ardelyx Inc is a biotechnology company focused on the discovery, development, and commercialization of innovative, first-in-class medicines that meet significant unmet medical needs. The company has a proprietary drug discovery and design platform. Its lead product candidate is tenapanor, which aims to reduce the absorption of dietary sodium and phosphorus for the treatment of kidney disease, irritable bowel syndrome with constipation, and hyperphosphatemia in patients with dialysis.
Share on Social Networks:
0